| Visualizaciones | |
|---|---|
| An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer | 16 |
| diciembre 2025 | enero 2026 | febrero 2026 | marzo 2026 | abril 2026 | mayo 2026 | junio 2026 | |
|---|---|---|---|---|---|---|---|
| An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer | 0 | 0 | 0 | 0 | 16 | 0 | 0 |
| Visualizaciones | |
|---|---|
| fphar-16-1605314.pdf | 5 |
| supplementary file.pdf | 1 |
| image 1,2.pdf | 1 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 8 |
| Perú | 2 |
| Argentina | 1 |
| Grecia | 1 |
| Visualizaciones | |
|---|---|
| Newark | 4 |
| Lima | 2 |
| San Mateo | 2 |
| Athens | 1 |
| Federal | 1 |